日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD(+) acute myeloid leukemia.

在 FLT3-ITD(+) 急性髓系白血病的临床前模型中评估吉瑞替尼联合化疗的疗效

Ueno Yoko, Mori Masamichi, Kamiyama Yoshiteru, Saito Rika, Kaneko Naoki, Isshiki Eriko, Kuromitsu Sadao, Takeuchi Masahiro